1. Home
  2. COEP vs FUSB Comparison

COEP vs FUSB Comparison

Compare COEP & FUSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • FUSB
  • Stock Information
  • Founded
  • COEP 2017
  • FUSB 1952
  • Country
  • COEP United States
  • FUSB United States
  • Employees
  • COEP N/A
  • FUSB N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • FUSB Major Banks
  • Sector
  • COEP Health Care
  • FUSB Finance
  • Exchange
  • COEP Nasdaq
  • FUSB Nasdaq
  • Market Cap
  • COEP 86.0M
  • FUSB 69.5M
  • IPO Year
  • COEP N/A
  • FUSB N/A
  • Fundamental
  • Price
  • COEP $15.29
  • FUSB N/A
  • Analyst Decision
  • COEP
  • FUSB
  • Analyst Count
  • COEP 0
  • FUSB 0
  • Target Price
  • COEP N/A
  • FUSB N/A
  • AVG Volume (30 Days)
  • COEP 66.5K
  • FUSB 3.4K
  • Earning Date
  • COEP 11-12-2025
  • FUSB 10-28-2025
  • Dividend Yield
  • COEP N/A
  • FUSB 2.31%
  • EPS Growth
  • COEP N/A
  • FUSB N/A
  • EPS
  • COEP N/A
  • FUSB 0.97
  • Revenue
  • COEP $263,555.00
  • FUSB $36,046,000.00
  • Revenue This Year
  • COEP N/A
  • FUSB N/A
  • Revenue Next Year
  • COEP N/A
  • FUSB N/A
  • P/E Ratio
  • COEP N/A
  • FUSB $12.84
  • Revenue Growth
  • COEP N/A
  • FUSB N/A
  • 52 Week Low
  • COEP $2.31
  • FUSB $10.30
  • 52 Week High
  • COEP $19.19
  • FUSB $14.30
  • Technical
  • Relative Strength Index (RSI)
  • COEP 49.85
  • FUSB 49.63
  • Support Level
  • COEP $14.90
  • FUSB $12.15
  • Resistance Level
  • COEP $16.17
  • FUSB $12.45
  • Average True Range (ATR)
  • COEP 1.17
  • FUSB 0.13
  • MACD
  • COEP -0.30
  • FUSB 0.02
  • Stochastic Oscillator
  • COEP 11.94
  • FUSB 55.56

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About FUSB First US Bancshares Inc.

First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.

Share on Social Networks: